OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting
01 Mai 2023 - 2:00PM
OrthoPediatrics Corp. (“OrthoPediatrics” or the
“Company”) (Nasdaq: KIDS) a company focused exclusively on
advancing the field of pediatric orthopedics, today announced its
continued support of the 2023 Pediatric Orthopaedic Society of
North America (“POSNA”) annual meeting this week in Nashville,
Tennessee.
At the Annual Meeting the Company highlighted
its growing portfolio of pediatric-specific solutions at its
exhibit booth. The Company sponsored a sub-specialty session
focused on hip dysplasia in pediatric patients. This session
covered two extreme and regularly occurring situations, including
stable dysplasia in infants as well as severe dysplasia and
degeneration in adolescents. Additionally, the Company highlighted
progress with the ApiFix non-fusion technology, hosting a workshop
for current users of the system to share their experiences and
best-practice, as well as discuss positive one-year ApiFix
follow-up clinical data from 54 patients in the registry who are
over one-year post surgery.
OrthoPediatrics has established a longer-term
commitment to POSNA deepening its commitment to providing ongoing
support of specialty symposiums and awarding educational grants and
scholarships to attendees. The Company has elevated its sponsorship
level and is now the only Emerald Sponsor of the organization.
OrthoPediatrics’ President & CEO, David
Bailey, commented, “We are very excited to establish a larger
commitment to POSNA following our long-standing collaboration with
the prestigious society. This new multi-year commitment is of the
highest level and is a further testament to our dedication to
providing industry-leading clinical education and training. With
over 1,500 members, POSNA continues to be an influential society
for pediatric orthopedic surgeons, and we are proud to support the
organization and its membership.”
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an
orthopedic company focused exclusively on advancing the field of
pediatric orthopedics. As such it has developed the most
comprehensive product offering to the pediatric orthopedic market
to improve the lives of children with orthopedic
conditions. OrthoPediatrics currently markets 48 surgical
systems that serve three of the largest categories within the
pediatric orthopedic market. This product offering spans trauma and
deformity, scoliosis, and sports medicine/other procedures.
OrthoPediatrics’ global sales organization is focused exclusively
on pediatric orthopedics and distributes its products in the
United States and over 70 countries outside the United
States. For more information, please
visit www.orthopediatrics.com.
Investor ContactPhilip Trip
Taylor Gilmartin Groupphilip@gilmartinir.com415-937-5406
OrthoPediatrics (NASDAQ:KIDS)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
OrthoPediatrics (NASDAQ:KIDS)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024